scholarly journals Genetic characteristics of a patient with multiple primary cancers: A case report

2021 ◽  
Vol 9 (28) ◽  
pp. 8563-8570
Author(s):  
Wei-Wei Ouyang ◽  
Qing-Yun Li ◽  
Wen-Gang Yang ◽  
Sheng-Fa Su ◽  
Li-Jia Wu ◽  
...  
2011 ◽  
Vol 29 (15_suppl) ◽  
pp. e11047-e11047
Author(s):  
V. D. Petrova ◽  
E. L. Sekerzhinskaya ◽  
I. A. Selezneva ◽  
T. V. Sinkina ◽  
S. A. Terekhova ◽  
...  

Author(s):  
Terrab Fatima Zahrae ◽  
Allouche Fadwa ◽  
El Mazghi Abdelrahmane ◽  
Bouhafa Touria ◽  
Hassouni Khalid

2020 ◽  
Vol 73 (5-6) ◽  
pp. 170-174
Author(s):  
Marko Jevric ◽  
Emilija Filipovic ◽  
Ana Krivokuca

Introduction. The occurrence of more than one primary cancer in the same patient is not very common. Multiple cancer prevalence is about 7.9% and the percentage is lower as the number of multiple primary cancers is higher. The incidence of four or more primary cancers in one patient is very rare and its prevalence is around 0.07%. Case Report. We report a rare case of a female with four histopathologically confirmed primary malignant neoplasms. The first tumor was endometrial carcinoma diagnosed at the age of 52. Three additional metachronous tumors were diagnosed as follows: left breast cancer, melanoma, and contralateral breast cancer. Extensive genetic testing was performed and 19 genes were sequenced using the next generation sequencing (BRCA1, BRCA2, ATM, BRIP1, CDH1, CHEK2, MSH2, MLH1, MSH6, PMS2, EPCAM, NBN, NF1, PALB2, PTEN, RAD51C, RAD51D, STK11 and TP53). Even with the existing indicators of genetic etiology, this case showed no pathogenic mutations in any of these genes. This indicates the existence of other underlying mechanisms such as hormonal factors, previous treatment of the primary and subsequent tumors, environmental factors, gene-gene and gene-environment interactions, as well as immunosuppression that could increase the risk for the second and subsequent malignancies. Conclusion. Detailed information on the biology of multiple primary tumors is important for both clinicians and cancer patients during medical management following primary treatment. In addition, genetic information is very important because it has future implications for both patients and their family members.


2021 ◽  
pp. 42-43
Author(s):  
Sandeep Ghosh ◽  
Bonny Joseph ◽  
Vinod Dhakad ◽  
Sanjay Desai

Cancer is a serious health problem worldwide, being responsible from ¼ of all deaths. Cancers developing from more than one origin are called multiple primary cancers (MPCs) and is a rare entity with a reported frequency of 0.73%–11%. There are no guidelines for the management of synchronous tumours. Because of this, development of patient-oriented treatment strategy is necessary to decide which cancer to treat rst and how to stratify further treatments. We present a case with synchronous sporadic breast and colon cancer. If adjuvant therapy is required, it should be directed towards the tumour with the more advanced stage. The prognosis of synchronous tumours depends on each tumour stage independently


2020 ◽  
Vol 2020 ◽  
pp. 1-5
Author(s):  
Tyler B. Torina ◽  
Emily L. Hudspeth ◽  
Joon Min Chun ◽  
William Zaloga ◽  
Carlisle Alderink ◽  
...  

Multiple primary cancers, although uncommon, have been increasing in incidence in recent years. This trend is likely due to advances in factors such as diagnostic imaging, life expectancy, and interventional modalities with associated adverse effects. The patient presented in this case report is a 59-year-old Caucasian female with an extensive medical history who developed multiple primary cancers of the breast, mouth, gastrointestinal system, and lung in the span of four years. We attempted to elucidate the possible etiologies and risk factors that may have contributed. Given the patient’s complex medical and social history, interventions, environmental, and genetic predispositions, it is impossible to pinpoint a single etiology. Rather, it is more likely that the interplay of multiple factors contributed to the findings of this case.


2020 ◽  
Author(s):  
Mengfan Zhao ◽  
Lusha Bi ◽  
Bin Wu

Abstract Introduction Reports of synchronous multiple primary cancers in patients with breast cancer have recently been increasing because of progress in radiographic diagnostic techniques. Multiple primary cancers in patients with breast cancer mainly occur in the lung and endometrium. Case report We report a 37-year-old female patient diagnosed with synchronous double primary cancers, namely invasive ductal carcinoma of the left breast and invasive carcinoma of inferior lobe of the right lung based on the pathological examination. After MDT, we gave her both lung and breast surgery then adjuvantchemothrapy(AC-T) and EGFR-TKI (Gefitinib). We followed this patient until October, 2020, the patient was healthy and with no clinical or radiologic signs of recurrent or metastatic disease at the time of this writing.Discuss The pathogenesis of MPCs is still unclear, which is closely related to many factors, such as genetic, immune, iatrogenic, endocrine, lifestyle. The diagnosis depends on chest CT and Pathology examination. And there is no standard treatment guideline for MPCs. The specific therapy plan should be made after MDT discussion.Conclusion Multiple synchronous breast and lung adenocarcinoma in one patient dose not like metastatic carcinoma. If the treatment is in time, the patient can also get a good prognosis.


Sign in / Sign up

Export Citation Format

Share Document